Request for Applications: Joint Call for Research Projects on Tuberculosis
The South African Medical Research Council (SAMRC) is pleased to announce a joint research call on Tuberculosis (TB), in partnership with ANRS MIE (Emerging Infectious Diseases). TB remains a leading global infectious disease, with millions of new cases reported annually. This initiative aims to accelerate progress in addressing the global burden of TB through international research collaboration.
This joint call seeks to support research and innovation projects that cover the full spectrum of TB disease, including subclinical and drug-resistant TB. Research proposals are invited to address the following major topics in both adults and children:
- Epidemiology, pathogenesis, transmission and management of sub-clinical TB.
- Identification of biomarkers for disease progression and the development of novel diagnostics based thereon;
- Development of rapid diagnostic tools for evaluating drug resistance and for precision medicine in the management of TB;
- Development of new vaccine strategies, including new candidates to fill the vaccine development pipeline and strategies for feasibility and implementation of new vaccines that come onto the market.
- Evaluation of new drugs or shortened regimens, especially for pediatric populations.
Only proposals with co-Principal Investigators from both South Africa and France will be eligible for funding. To support collaboration, we offer a matchmaking platform where researchers from South Africa and France can connect. Please complete the matchmaking form and review the dashboard: https://redcap.link/researcher-match
The call opened on 02 August 2024, and further details on how to apply can be found on the ANRS MIE website: Joint request for applications between ANRS MIE and SAMRC - ANRS Joint request for applications,Tuberculosis
Application Deadline: 31 October 2024, 11:59 PM CET (10:59 PM UTC) - Proposals submitted after this deadline will not be accepted.
